b.

baseimmune.

data-driven vaccine design platform 

About Us

baseimmune is a biotech startup founded to create the next generation of vaccines. Our unique platform is based on innovative and powerful technology which is able to generate antigens using a level of informatics depth not previously seen. 


Using this approach we are able to tackle emerging and challenging pathogens that had been failed by traditional approaches and importantly able to ensure our vaccines remain effective even if a pathogen mutates.


As a discovery phase biotech, we offer our antigen discovery services and develop broad-spectrum vaccines against highly variable pathogens. 

b.

Technology

We utilise deep-learning techniques to monitor pathogen dynamics, predicting forthcoming changes in emerging pathogens and generate vaccines which are effective against all current and future unknown strains

Our technologies are based on a data-driven platform for the analysis of pathogen genomics, proteomics, epidemiology, evolution and clinical data. Targeted at the faster and cheaper development of effective and safe rationally designed vaccines. 

Platform

Platform

inputs

inputs

Deep

Deep

learning

learning

Vaccine

Vaccine

candidates

candidates

Team

Co-founder, CEO

Co-founder, CTO

Co-founder, CSO

Prof. Martin

Bachmann, PhD

Dr. Danny

Goovaerts, PhD

Prof. Jake

Baum, PhD

Scientific Advisor

Scientific Advisor

Scientific Advisor

With talented vaccine experts, scientists, bioinformaticians and software engineer in the field, baseimmune is committed to translating ‘OMICs’ big-data into real-world solutions. By collaborating with leading institutions and companies and an expert panel of scientific advisors, we hope to develop  vaccines and reduce the burden of infectious diseases in human and animal health.

Pipeline

The baseimmune pipeline currently focuses on major challenges in infectious diseases. We are building a unique pipeline to address veterinary and human threats worldwide.  

BSIvet-001 vaccine  1

BSIundisclosed

DESIGN

PRECLINICAL

PHASE I

African Swine Fever

BSIvet-001 vaccine  2

BSIvet-001 vaccine 3

SARS-CoV-2

BSIhum-002 vaccine 1

Undisclosed Vaccine

Our bespoke antigen discovery platform allied with superior vaccine delivery systems, allow us to fast track the discovery phase of vaccines and move faster to preclinical pipeline. 

baseimmune joins cohort 2 of the KQLabs accelerator program held at the Crick Institute

baseimmune features in UKSpine article about startups from academics

News

InnovateUK award to develop vaccine

baseimmune awarded a technology accelerator grant by InnovateUK,

b.

Who are we?

meet the baseimmune team and find out what we do

n

n

World-Class Partners

Working with world-class research institutes

Funders

We are funded and supported by the Innovate UK, the UK Innovation and Science fund and the  KQ labs accelerator. 

Contact

If you’d like to know more, contact us.

Email Us

baseimmune

TM

© 2020 baseimmune. All rights reserved